NCT00594425

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: Photocure · Industry
• Sex: All
• Age: 15 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

This multicenter study will be divided into 2 phases. The first phase will be an open label, dose-escalation phase, while the second will be a blinded, randomized, vehicle-controlled, parallel-group, dose-response phase. The second phase will only start if the first phase succeeds in establishing well tolerated dose(s). Patients with moderate to severe acne vulgaris in the face will be included.The results from part 2 has been presented in the result section.

Detailed description

For the second part: All patients will receive 4 PDT sessions 2 weeks apart using a light dose of 37 J/cm2. One treatment group will receive vehicle cream, while the other 2 groups will receive MAL cream with a concentration of 40 mg/g and 80 mg/g, respectively. The MAL and vehicle cream will be applied in a thin layer on clean skin and left for 1.5 hours under occlusion before illumination.

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
DRUG	Methyl aminolevulinate (MAL) PDT	Cream application followed by illumination with red light

Timeline

• Start date: 2007-02-01
• Primary completion: 2008-07-01
• Completion: 2008-09-01
• First posted: 2008-01-15
• Last updated: 2013-08-08
• Results posted: 2013-08-08

Locations

14 sites across 1 country: United States